CatalystPit

TKNOAlpha Teknova, Inc.

NASDAQ · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Last close $8.90 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market cap$477.83M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-16 · DEMSKI MARTHA J (Director) · OTHER
  • 2026-03-09 · Lowell Matthew (Chief Financial Officer) · BUY
  • 2026-03-09 · Gunstream Stephen (President and CEO) · BUY
  • 2025-07-01 · DEMSKI MARTHA J (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders84
Shares held9,756,337
Value$53.77M
Percent of shares outstanding18.17%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-08-12 · Richard Blumenthal · SELL · $1,001 - $15,000
  • 2026-08-11 · Richard Blumenthal · SELL · $15,001 - $50,000
  • 2026-08-11 · Richard Blumenthal · SELL · $1,001 - $15,000
  • 2026-08-10 · Richard Blumenthal · BUY · $1,001 - $15,000
  • 2026-08-10 · Richard Blumenthal · SELL · $1,001 - $15,000
RECENT NEWS
  • Jefferies initiates Alpha Teknova with buy rating on growth outlook
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Alpha Teknova, Inc. (TKNO) · Stock Price, Insider Trades, Congress Trades · CatalystPit